More Proof The Flu Vaccine Works

Feb 16 2014, 10:44am CST | by

A Duke University Medical Center study released this past week shows that among this season’s influenza patients sick enough to end up in their intensive care unit, 91% had failed to receive this year’s seasonal flu vaccine.

And for those admitted to the hospital, but with less severe disease not requiring an ICU stay, 67% weren’t vaccinated.

(Disclosure: I’ve held an unpaid, adjunct faculty appointment in Duke University’s Department of Medicine since 2002.).

The study was published online Monday in the American Journal of Respiratory and Critical Care Medicine.

The Duke study examined only the 55 patients admitted to this tertiary-care hospital between November 1, 2013 and January 8, 2014. But the cases were very well-characterized and represented substantial racial diversity, with the patients self-identifying as 47% Caucasian, 42% African-American and 6% Hispanic.

The median age of the patients in the study was 28.5, with 49% of them aged 18 to 49. Another 33% were in the 50 to 64 age group.

These numbers – 8 out of 10 seriously ill patients being young- or middle-aged adults – are consistent with the national trend observed with this year’s most prevalent circulating flu strain, called 2009 pH1N1*. This distribution stands in contrast to most years where infants, toddlers, and seniors are most at risk, although these groups are always at high risk every year.

The researchers also looked closely at the hospitalized patients who received the flu vaccine within two weeks of their hospitalization in hopes of determining how they still ended up sick. The two vaccinated patients of 22 that still ended up in the ICU had disorders that likely rendered them immunocompromised and less likely to mount a sufficient, protective response to the vaccine. Similar confounding situations that would likely suppress immune function were also observed almost all of the non-ICU, hospitalized patients who were vaccinated.

In a telephone interview, Duke infectious disease physician and study co-author, Cameron R. Wolfe, M.D. suggested that public health education efforts might better focus on the major preventive effect the vaccines have on disease incidence and severity.

Wolfe said, “We often talk about the vaccine preventing mortality because that’s the hard, easy-to-measure outcome. But a major point of the paper is that we should also be talking about the vaccines having a separate benefit in terms of morbidity.”

The major, take-home point, Wolfe explains, is that, “Even you get influenza, the vaccine reduces the likelihood of truly serious disease.”

Being admitted to an ICU with respiratory complications of influenza presents a far more convoluted hospital experience than for those who only required three or four days of treatment on the general medicine service.

“These people on the intensive care unit are very sick. If you end up there, you’re going to be battling a month or more of hospitalization,” says Wolfe.

“Some of the people we report on in the paper are still in the hospital. And if you survive, you’re looking at many weeks of rehabilitation.”

In fact, five of the 22 ICU patients had died by the time the paper was accepted for publication.

Across North Carolina, where Duke is located, public health officials said Friday that seven more influenza-related deaths were reported for the week ending February 8th, bringing the state’s total influenza death count to 64 for this season.

Don’t withhold antiviral drugs

Wolfe and colleagues also raised a serious concern regarding the effectiveness of the rapid influenza diagnostic test (RIDT) used both in doctor’s offices in the community and hospitals. About a third of the patients in the ICU had previously received a negative influenza test result. Unfortunately, this high false negative rate appears to have delayed many of the patients from getting antiviral drug therapy, most commonly oseltamvir phosphate (Tamiflu; Genentech) or, to a lesser extent, zanamivir (Relenza; GlaxoSmithKline).

In citing a large, meta-analysis that concluded that the RIDT is only about 63% accurate, the authors stated that:

“The CDC recommends that the decision regarding antiviral treatment of influenza should not await laboratory confirmation and that indications for antiviral treatment include hospitalization, severe complicated and progressive illness, and presence of risk factors for influenza complications, independent of the duration of symptoms.”

Dr. Wolfe added, “The physiological cost of the drug is small [in terms of side effects], the financial cost of the drug is small – so we argue to put the patient on the drug immediately.”

If subsequent testing is negative by the more accurate polymerase chain reaction (PCR) test of samples obtained from deeper in the lung, Wolfe says the drug can always be discontinued.

Yes, you can (and should) still get your vaccine

We’ve all heard public health officials urge us to get one of the vaccines for influenza. True influenza-related illnesses, not just those colds that we call “the flu,” cause between 3,000 and 49,000 deaths in the U.S. each year.

But in support of the protective effect of the vaccine on morbidity, as alluded to by Dr. Wolfe, the CDC estimates that last year’s vaccine prevented 79,000 influenza-related hospitalizations and 6.6 million illnesses. The remarkable success of the vaccine isn’t always at the forefront of public perception because, as with all public health measures, we don’t see the disease cases that were prevented.

As shown in this study, this year’s vaccine was very likely to protect a representative subset of flu patients from serious, potentially fatal respiratory illness. Moreover, the results from Wolfe and colleagues strongly argue the need for people 18 to 64 to be vigilant every year and get their seasonal influenza vaccine. This is especially true in individuals with an underlying predisposition to respiratory diseases such as asthma or other conditions such as diabetes and cardiovascular disease.

Even now in mid-February, it’s not too late to get your vaccine, as 29 states are still reporting widespread flu activity as of February 1st.

Since the vaccine takes 10 to 14 days to elicit a protective immune response, Dr. Wolfe says that getting it in the next two weeks is critical. And for people with allergies to eggs, the production system for most flu vaccines, an egg-free vaccine called Flublok is now available from Protein Sciences.

Influenza-like illness, the type reported from outpatient clinics, is especially high in Texas, Oklahoma, Kansas, and Arkansas. See the CDC’s interactive Fluview page for the latest information.

*The precise strain is A/California/7/2009/(H1N1)pdm09-like virus. The other influenza A hemagglutinin antigen in the 2013-2014 vaccines was from an A/(H3N2) that’s antigenically-similar to the cell propagated virus, A/Victoria/361/2011. The HA protein of an influenza B strain, B/Massachusetts/2/2012-like (B/Yamagata lineage) virus, was also included in this season’s vaccines. The two influenza A strains are the same as those in the 2012-2013 vaccines.

Source: Forbes Business

 
 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

For Working Women, Focus On Beauty Erodes Self Confidence
In a guest post last month, “‘Princeton Mom’ Gives Dumb Advice On Marrying Smart,” Lisa Endlich Heffernan rebutted the argument that smart girls who don’t find husbands in college are destined for spinsterhood. Here she...
 
 
A Compelling Case for the Mid Cap Value ETF (IWS)
U.S. equity markets have struggled to maintain the bullish momentum seen throughout 2013. While the broader market has managed to stay afloat, certain sectors have fallen from the record highs enjoyed last year;...
 
 
CDC Would Sacrifice Kids To Cut Healthcare Costs
The U.S. Centers for Disease Control and Prevention (CDC) appears to have assumed a role that was never intended: reducing the ability of vaccines to save lives.  At their past two meetings, the CDC’s vaccine advisory...
 
 
How You'll Know It's Time To Kill Off One Of Your Products or Services
I got this question the other day. It seemed like a good idea when I started.  But, I am not making any money on my offering, nor do I seem to be gaining traction.  Is there any clear benchmark on when I should shut...
 
 
 

Latest from the Network

Laura Prepon: Tom Cruise is hot
Laura Prepon thinks Tom Cruise is "hot". The 'Orange is the New Black' actress insists rumors she is dating the 'Mission: Impossible' star are untrue, but she is "flattered" by the speculation, even though she finds it...
Read more on Celebrity Balla
 
Meryl Streep tired of awards
Meryl Streep "hates" inviting people to awards ceremonies. The 64-year-old actress - who has been nominated for an Oscar 18 times and won three of the coveted statuettes - picked up the 14th annual Monte Cristo Award by...
Read more on Celebrity Balla
 
Leslie Mann regrets using marriage as inspiration for This Is 40
Leslie Mann regrets using her marriage as inspiration for 'This Is 40'. The 'Other Woman' star admits she became "annoyed" by the "invasive" questions about her relationship with director Judd Apatow when she starred...
Read more on Celebrity Balla
 
A Compelling Case for the Mid Cap Value ETF (IWS)
U.S. equity markets have struggled to maintain the bullish momentum seen throughout 2013. While the broader market has managed to stay afloat, certain sectors have fallen from the record highs enjoyed last year;...
Read more on Business Balla
 
CDC Would Sacrifice Kids To Cut Healthcare Costs
The U.S. Centers for Disease Control and Prevention (CDC) appears to have assumed a role that was never intended: reducing the ability of vaccines to save lives.  At their past two meetings, the CDC’s vaccine advisory...
Read more on Business Balla
 
Apple vs. Samsung Patent Case Pulls Google Into The Spotlight To Back Its Android Partner
There are a lot of interesting facts, presentations, and historical detail coming out of the Apple vs. Samsung patent case currently under way. It is also slowly reeling in Google’s flavour of Android into the spotlight...
Read more on Apple Balla
 
Quentin Tarantino's Gawker lawsuit dismissed
Quentin Tarantino's lawsuit against Gawker has been dismissed. The award-winning director was furious when the website posted a link to a leaked copy of his 'Hateful Eight' script, forcing him to scrap plans for the...
Read more on Movie Balla
 
Catherine Hardwicke to helm Miss You Already
Catherine Hardwicke will direct 'Miss You Already'. The 58-year-old filmmaker will helm the picture which has Rachel Weisz and Toni Collette attached to star while Morwenna Banks penned the script based on personal...
Read more on Movie Balla
 
How You'll Know It's Time To Kill Off One Of Your Products or Services
I got this question the other day. It seemed like a good idea when I started.  But, I am not making any money on my offering, nor do I seem to be gaining traction.  Is there any clear benchmark on when I should shut...
Read more on Business Balla
 
New Impact Investment Fund At Columbia Launched To Solve Big Social Problems
A team of young social entrepreneurs has created an impact investing fund at Columbia University called 118 Capital that will operate as a nonprofit. The founders all have recent degrees from Columbia. 118 Capital will...
Read more on Business Balla
 
 
Auto Balla Sexy Balla Sport Balla TV Balla Politics Balla Movie Balla Apple Balla Business Balla Ad Balla Celebrity Balla